CLVT - Clarivate Plc Stock Price, Fair Value and News

$4.98+0.08 (+1.63%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CLVT Price Action

Last 7 days

-2.5%

Last 30 days

-2.2%

Last 90 days

-28.2%

Trailing 12 Months

-46.1%

CLVT RSI Chart

CLVT Valuation

Market Cap

3.5B

Price/Earnings (Trailing)

-2.75

Price/Sales (Trailing)

1.37

EV/EBITDA

-13.85

Price/Free Cashflow

8.32

CLVT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CLVT Fundamentals

CLVT Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

-3.86%

Rev. Growth (Qtr)

-4.32%

CLVT Earnings

Earnings (TTM)

-1.3B

Earnings Growth (Yr)

-633.33%

Earnings Growth (Qtr)

78.44%

CLVT Profitability

Operating Margin

66.12%

EBT Margin

-49.80%

Return on Equity

-23.38%

Return on Assets

-10.71%

Free Cashflow Yield

12.02%

CLVT Investor Care

Shares Dilution (1Y)

7.00%

Diluted EPS (TTM)

-1.98

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.6B	2.6B	2.6B	0
2023	2.6B	2.6B	2.6B	2.6B
2022	2.1B	2.4B	2.5B	2.7B
2021	1.4B	1.6B	1.8B	1.9B
2020	980.9M	1.0B	1.1B	1.3B
2019	965.5M	964.5M	964.6M	974.3M
2018	930.3M	943.1M	955.8M	968.5M
2017	0	0	0	917.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Clarivate Plc

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CEO	Mr. Jonathan Gear
WEBSITE	clarivate.com
SECTOR	Technology
INDUSTRY	Information Technology Services
EMPLOYEES	11600

Clarivate Plc Frequently Asked Questions

What is the ticker symbol for Clarivate Plc? What does CLVT stand for in stocks?

CLVT is the stock ticker symbol of Clarivate Plc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clarivate Plc (CLVT)?

As of Fri Dec 20 2024, market cap of Clarivate Plc is 3.54 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLVT stock?

You can check CLVT's fair value in chart for subscribers.

Is Clarivate Plc a good stock to buy?

The fair value guage provides a quick view whether CLVT is over valued or under valued. Whether Clarivate Plc is cheap or expensive depends on the assumptions which impact Clarivate Plc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLVT.

What is Clarivate Plc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, CLVT's PE ratio (Price to Earnings) is -2.75 and Price to Sales (PS) ratio is 1.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLVT PE ratio will change depending on the future growth rate expectations of investors.